Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 5/20 | 0.43 |
| ▸ | TDO2 | P48775 | 5/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | DHODH | Q02127 | 8/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17636681 | 0.92 | IDO1 (0.42) | IDO1TDO2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL21532500 | 0.92 | IDO1 (0.37) | IDO1TDO2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17636627 | 0.90 | IDO1 (0.43) | IDO1TDO2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL21532771 | 0.89 | IDO1 (0.37) | IDO1TDO2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL21532506 | 0.88 | IDO1 (0.36) | IDO1TDO2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL21532761 | 0.87 | IDO1 (0.34) | IDO1TDO2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL21532749 | 0.87 | IDO1 (0.34) | IDO1TDO2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17636818 | 0.87 | IDO1 (0.49) | IDO1TDO2DHODHGAA | |
| SCHEMBL17636658 | 0.87 | IDO1 (0.47) | IDO1TDO2DHODHL3MBTL1GAA | |
| SCHEMBL21532496 | 0.87 | IDO1 (0.35) | IDO1TDO2NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9960365-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-9960365-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-20160093811-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-03-31 | — | — | US | disclosed |
| US-20160093811-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160093811-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, CCNA1 | IDO1 3268/4885TDO2 3216/4885NPC1 2223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.